AxoGen Inc. (AXGN) CEO Acquires $75,000.00 in Stock
AxoGen Inc. (NASDAQ:AXGN) CEO Karen L. Zaderej acquired 10,000 shares of the business’s stock in a transaction that occurred on Friday, October 7th. The stock was purchased at an average price of $7.50 per share, for a total transaction of $75,000.00. Following the acquisition, the chief executive officer now directly owns 242,147 shares in the company, valued at approximately $1,816,102.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of AxoGen Inc. (NASDAQ:AXGN) remained flat at $8.72 during midday trading on Friday. The stock had a trading volume of 271,897 shares. AxoGen Inc. has a 1-year low of $4.08 and a 1-year high of $9.88. The company’s market capitalization is $262.75 million. The company’s 50 day moving average is $8.74 and its 200 day moving average is $6.97.
AxoGen (NASDAQ:AXGN) last released its quarterly earnings results on Wednesday, August 3rd. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.03. AxoGen had a negative return on equity of 193.60% and a negative net margin of 37.90%. On average, equities research analysts anticipate that AxoGen Inc. will post ($0.40) earnings per share for the current fiscal year.
Separately, Wedbush reiterated an “outperform” rating and issued a $10.00 price objective (up previously from $9.00) on shares of AxoGen in a report on Thursday, August 4th.
A number of institutional investors have recently added to or reduced their stakes in AXGN. Waddell & Reed Financial Inc. bought a new position in AxoGen during the second quarter valued at $1,371,000. State Street Corp bought a new position in AxoGen during the second quarter valued at $1,885,000. Rhumbline Advisers bought a new position in AxoGen during the second quarter valued at $132,000. Teachers Advisors Inc. bought a new position in AxoGen during the second quarter valued at $267,000. Finally, TFS Capital LLC bought a new position in AxoGen during the second quarter valued at $113,000. 57.99% of the stock is owned by institutional investors.
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.